SVF Endurance (Cayman) Ltd, 10% Owner at Vir Biotechnology, Inc. (VIR), sold 88,338 shares at $25.55 ($2.3M) on 2022-12-29, disclosed to the SEC on 2023-01-03.
Open-market sale of $2.3M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.55 | 44,169 | $1.1M | 50.0% |
| 2 | $25.55 | 44,169 | $1.1M | 50.0% |
| Total | $25.55 avg | 88,338 | $2.3M | 100% |
| Filing → |
| VIR | SELL | 2025-10-30 | $319K | — | Filing → |
| VIR | SELL | 2025-10-22 | $2.7M | — | Filing → |
| VIR | SELL | 2025-10-17 | $359K | — | Filing → |